These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 9667236)

  • 1. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term effect of LDL apheresis on coronary heart disease.
    Donner MG; Richter WO; Schwandt P
    Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term (14 years) effect of LDL apheresis on obstructive changes in aortocoronary saphenous-vein bypass grafts in a case of heterozygous familial hypercholesterolemia with the LDL receptor proline664 to leucine mutation.
    Takahashi K; Kobayashi J; Bujo H; Takahashi M; Taira K; Kaneko K; Tashiro J; Shinomiya M; Miyazaki A; Saito Y
    Intern Med; 2000 Oct; 39(10):804-9. PubMed ID: 11030204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS).
    Nishimura S; Sekiguchi M; Kano T; Ishiwata S; Nagasaki F; Nishide T; Okimoto T; Kutsumi Y; Kuwabara Y; Takatsu F; Nishikawa H; Daida H; Yamaguchi H
    Atherosclerosis; 1999 Jun; 144(2):409-17. PubMed ID: 10407502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.
    Reijman MD; Tromp TR; Hutten BA; Hovingh GK; Blom DJ; Catapano AL; Cuchel M; Dann EJ; Gallo A; Hudgins LC; Raal FJ; Ray KK; Sadiq F; Soran H; Groothoff JW; Wiegman A; Kusters DM; ;
    Lancet Child Adolesc Health; 2024 Jul; 8(7):491-499. PubMed ID: 38759658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia.
    Tsuchida M; Kawashiri MA; Tada H; Takata M; Nohara A; Ino H; Inazu A; Kobayashi J; Koizumi J; Mabuchi H; Yamagishi M
    Circ J; 2009 May; 73(5):963-6. PubMed ID: 19088396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative long-term experience with immunoadsorption and dextran sulfate cellulose adsorption for extracorporeal elimination of low-density lipoproteins.
    Knisel W; Pfohl M; Müller M; Besenthal I; di Nicuolo A; Voelker W; Risler T; Eggstein M
    Clin Investig; 1994 Sep; 72(9):660-8. PubMed ID: 7849443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy.
    Masaki N; Tatami R; Kumamoto T; Izawa A; Shimada Y; Takamatsu T; Katsushika S; Ishise S; Maruyama Y; Yoshimoto N
    Int Heart J; 2005 Sep; 46(5):833-43. PubMed ID: 16272774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: a 4 year follow-up study.
    Fadul JE; Vessby B; Wikström B; Danielson BG
    Artif Organs; 1997 May; 21(5):364-8. PubMed ID: 9129767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
    Thompson GR; Maher VM; Matthews S; Kitano Y; Neuwirth C; Shortt MB; Davies G; Rees A; Mir A; Prescott RJ
    Lancet; 1995 Apr; 345(8953):811-6. PubMed ID: 7898227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS; Katz J; Ross J; Rader DJ
    J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
    Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
    Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: a long-term evaluation.
    Richter WO; Donner MG; Schwandt P
    Ther Apher; 1999 Aug; 3(3):203-8. PubMed ID: 10427616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia.
    Higashikata T; Mabuchi H
    Ther Apher Dial; 2003 Aug; 7(4):402-7. PubMed ID: 12887722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).
    Aengevaeren WR; Kroon AA; Stalenhoef AF; Uijen GJ; van der Werf T
    J Am Coll Cardiol; 1996 Dec; 28(7):1696-704. PubMed ID: 8962554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apheresis technology for prevention and regression of atherosclerosis.
    Yamamoto A; Harada-Shiba M; Kawaguchi A; Tsushima M
    Ther Apher; 2001 Aug; 5(4):221-5. PubMed ID: 11724504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol.
    Lappegård KT; Enebakk T; Thunhaug H; Hovland A
    Atherosclerosis; 2016 Aug; 251():119-123. PubMed ID: 27318831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass grafting in familial hypercholesterolemia.
    Kawasuji M; Sakakibara N; Takemura H; Matsumoto Y; Mabuchi H; Watanabe Y
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):364-9. PubMed ID: 7853888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.